Source disclosure: February 02, 2026

Daito Pharmaceutical Co., Ltd. [4577.T]

TOKYO, Feb 02 (Pulse News Wire) – Daito Pharmaceutical Co., Ltd. (4577.T) announced progress on its share repurchase program.

The company acquired 225,600 shares for a total of ¥303 million through open market purchases. The board authorized the repurchase of up to 1.00 million shares with a maximum expenditure of ¥1.5 billion.

The program is 59.7% complete with 597,200 shares acquired to date.

AI-translated content. 🟢 Confidence: High See termsOriginal filing

💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.
🎁 Report 3+ errors with your email and get a free month of premium access